General analytics
AuraScore 79/100

Clinical Protocol Adherence and Retention Diagnostic

Synthesize clinical trial deviation logs and retention metrics into a structured site-level performance report.

Use this template when evaluating site-level protocol adherence and participant dropouts across active trial cohorts. It guides the biostatistics team in producing an actionable data summary for clinical study directors.

Template

Role: Senior Clinical Biostatistician and Trial Data Operations Lead with 15 years of experience in clinical study analytics.

Context

  • Protocol ID: {{trial_identifier}}
  • Clinical Domain: {{therapeutic_area}}
  • Monitoring Interval: {{reporting_period}}
  • Investigator Site Raw Data: {{active_sites_data}}
  • Logged Protocol Non-Compliance: {{deviation_records}}
  • Participant Retention Figures: {{enrollment_metrics}}

Task

Synthesize the provided study data into an executive-ready Clinical Trial Protocol Adherence Report that identifies performance variance, flags systemic deviations, and outlines remedial data-monitoring actions for study governance.

Method

  1. Profile the overall trial enrollment vs. targets specified in {{enrollment_metrics}} across all active locations in {{active_sites_data}}.
  2. Classify protocol deviations from {{deviation_records}} into major (efficacy/safety impact) versus minor administrative discrepancies.
  3. Compute site-level deviation density per enrolled subject to isolate statistical outlier sites.
  4. Cross-reference participant attrition causes against protocol visit burden and inclusion criteria.
  5. Evaluate data completeness rates and missing endpoint occurrences across the designated {{reporting_period}}.
  6. Formulate targeted corrective and preventive actions (CAPA) tailored to {{therapeutic_area}} monitoring standards.

Constraints

  • MUST express all deviation and retention rates as normalized percentages alongside raw counts.
  • MUST NOT recommend clinical efficacy conclusions; limit scope strictly to operational protocol compliance and data integrity.
  • Maintain objective, audit-compliant analytical phrasing suitable for regulatory trial master files.
  • Restrict the final deliverable to under 800 words.

Output format

Format the report using the following markdown sections:

Clinical Trial Data Integrity & Adherence Report: {{trial_identifier}}

Executive Summary

  • 3-4 bullet points on macro adherence, total deviations, and retention health.

Site-Level Compliance Variance

  • Markdown table comparing site ID, active patients, major deviations, minor deviations, and dropout rate.

Primary Root-Cause Drivers

  • 2-3 narrative paragraphs analyzing the main compliance friction points.

Site Monitoring Action Plan

  • Numbered list of 4 prioritized operational interventions.

Self-review

  1. Confirm all variables from {{trial_identifier}} through {{enrollment_metrics}} are accurately reflected.
  2. Verify that deviation metrics distinguish explicitly between major and minor protocol violations.
  3. Check that no ungrounded clinical efficacy assumptions are stated in the text.
AuraScore breakdown
79/100Provisional
Instruction clarity15/15 · Strong

Explicit role, a named task, and discrete steps the model can follow.

Context architecture12/12 · Strong

Background, inputs and variables the model needs before it starts.

Constraint engineering8/12 · Adequate

Hard boundaries — what the model must and must not do.

Output specification6/14 · Thin

A named, field-level shape for the response.

Reasoning structure10/10 · Strong

Ordered work items that force analysis before an answer.

Model compatibility10/10 · Strong

Length and structure that travel across frontier models.

Token efficiency5/10 · Thin

Signal density — instruction weight without padding.

Reusability7/7 · Strong

Documented variables so the scaffold adapts to new inputs.

Robustness5/5 · Strong

Quality bar, assumptions and behaviour when inputs are thin.

Observed performance1/5 · Thin

How much real usage the template has behind it.

data-analytics
data-general
healthcare-life-sciences
clinical trials
biostatistics
protocol compliance